Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2009, Vol. 14 ›› Issue (7): 799-803.

Previous Articles     Next Articles

Development of pyrosequencing method for the simultaneous and rapid detection of CYP2C9*3 gene polymorphism and its reliability study

ZHAO Gang-tao1, DING Yuan-yuan1, YANG Fan1, LIU Hui-jun2, JIANG Nan1, XU Jing-feng1   

  1. 1Dept.of Pharmacology, General Hospital of Beijing Military Command, Beijing 100700, China;
    2The Central Hospital of Jiamusi, Jiamusi 154002, Heilongjiang, China
  • Received:2009-03-23 Revised:2009-07-26 Online:2009-07-26 Published:2020-10-30

Abstract: AIM: To establish a pyrosequencingbased method for simultaneous and rapid detection of CYP2C9*3 gene polymorphism.METHODS: With the results of standard ABI sequencing as a standard control, we observed and analyzed the reliability of the pyrosequencing method which involves the establishment of biotin-labeled primers, amplification of PCR, separation of Beads, preparation of pyrosequencing single-stranded template of mutational sites and sequencing of PyroMark ID in pyrosequencing apparatus by detected 220 cases of human DNA samples.RESULTS: We achieved the simultaneous and rapid detection platform of CYP2C9*3 mutation of DNA samples based on Pyrosequencing technology, which can detect DNA samples with high-flux manner.The test results of the CYP2C9*3 mutation of 96 DNA samples can be obtained each time with this detection platform.Compared with the standard ABI sequencing, the mutation detection rate and the repetition rate of CYP2C9*3 mutation are 100% in this method.CONCLUSION: Pyrosequencing method is a accurate, high-throughput, rapid method for the CYP2C9*3 mutation detection, especially suitable for the bulk detection of this mutation.

Key words: pyrosequencing, polymorphism, sequence analysis, CYP2C9

CLC Number: